What Diet Pill Stocks To Trade Alongside Orexigen Therapeutics (OREX, ARNA, VVUS)

Today Orexigen Therapeutics

received 13-7 FDA panel approval of its diet pill. What other stocks could be sympathy plays to this vote? If the FDA does provide final approval to Orexigen Therapeutics, it will be the first approval of a US prescription diet pill in a decade. This could be a significant vote of confidence to other stocks in this market, or as a sign of increased competition and possible less likelihood of approval. Arena Pharmaceuticals

are some stocks with similar products under FDA review. Vivus had news today regarding a FDA panel vote. As background, Contrave, Orexigen Therapeutics's first product, helped obese people lose an average of as much as 8.1 percent of their body weight, or 17 pounds (7.7 kilograms), after 56 weeks in a study reported in July. The most common side effect was nausea, experienced by almost one-third of patients taking the drug.